KROS
KEROS THERAP (KROS)
NASDAQ
$11.05+$0.02 (+0.14%)
Price as of Aug 21, 2026 4:10 PM EDT
  • $218.7M
    Market Cap
  • -29.11%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 59
Valuation
KROS
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
0

Momentum Score

Score: 37
Valuation
KROS
vs History
vs S&P 500
3-Month Momentum
2.32%
12-Month Momentum
-33.16%
3-Month Risk Adjusted Momentum
10.90%
12-Month Risk Adjusted Momentum
-70.12%

True Yield

N/A
Valuation
KROS
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
4.53%
Net Debt Paydown Yield
N/A

Financial Health Score

Score: 100
Valuation
KROS
vs History
vs S&P 500
Ohlson's O-Score
13